Glycomet GP 1 (Metformin/Glimepiride) Quantity:30 Tablet/s Its intravenous formulation allows for

Its intravenous formulation allows for rapid systemic distribution

Side effects of Apcalis Oral Jelly

Not for use in individuals with severe liver issues

and also enhances nitric-oxide availability causing peripheral vasodilation

Atrial fibrillation (stroke prevention): 5 mg twice daily

Glycomet GP 1 (Metformin/Glimepiride) Quantity:30 Tablet/s Its intravenous formulation allows forProduct Overview Glycomet GP 1 is a prescription medication formulated with a fixed dose combination of Metformin and Glimepiride, manufactured by USV Pvt Ltd. Designed specifically for the management of Type 2 diabetes mellitus, this tablet helps control blood glucose levels through complementary mechanisms of action. Each tablet contains 500 mg of Metformin and 1 mg of Glimepiride, packaged in a strip of 15 sustained release tablets providing